Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Financial Highlights Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023…
Financial Highlights Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023…
Two of six patients receiving NOX-A12 in combination with bevacizumab and radiotherapy exceeded 24-month survival si…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
The X-Smart Pro+ endodontic motor with integrated Apex Locator was recently honored with the international iF Design Awa…
VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 gene to retinal photoceptor t…
CeGaT, a global provider of genetic diagnostics and sequencing services based in Tübingen, Germany, is celebrating sever…
achelos GmbH, system house for cyber security and digital identity management, will be exhibiting at the DMEA event in B…
Arvato Systems Presents Future-Oriented and Sustainable Cloud and AI Solutions for University Clinics and Hospitals Data…
mymediset, the leading provider of SAP solutions for the medical device industry, and Terso Solutions, the leading provi…
FotoFinder Systems, a global leader in innovative skin imaging solutions, proudly announces the launch of skeen, a groun…